Live Breaking News & Updates on Beate Holz

Stay updated with breaking news from Beate holz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

STORM Therapeutics publishes data in Cancer Discovery showing induction of anti-tumour immunity by METTL3 inhibition

/PRNewswire/ STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies. ....

United Kingdom , Oliver Rausch , Mark Dawson , Jerry Mcmahon , Andrewa Guirguis , Peter Mac , Josefin Beate Holz , Peter Maccallum Cancer Centre , Therapeutics Ltd , Utokyo Innovation Platform Co Ltd , Taiho Ventures , Cambridge Innovation Capital , Fast Track Initiative , Ip Group , Seroba Life Sciences , Professor Mark Dawson , Chief Scientific Officer , Beate Holz , Chief Medical Officer , Chief Executive Officer , Yaara Ofir Rosenfeld , Cancer Discovery , Pfizer Ventures , Cambridge Innovation Capitali Limited , Maccallum Cancer Centre , Storm Therapeutics ,

Storm doses first patient with solid tumour drug candidate

Candidate is first molecule targeting an RNA methyltransferase enzyme to enter development - News - PharmaTimes ....

Jerry Mcmahon , Josefin Beate Holz , Beate Holz , Solid Tumour ,

STORM Therapeutics doses first patient with oral METTL3 targeting drug candidate in a solid tumor Phase 1 study

/PRNewswire/ STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying. ....

United Kingdom , Jerry Mcmahon , Josefin Beate Holz , Justin Moser , Therapeutics Ltd , Taiho Ventures , Clinical Investigator Of Honorhealth Research Institute , Merck Kga , Ip Group , Merck Kgaa , Fast Track Initiative , Cambridge Innovation Capital , University Of Tokyo Innovation Platform , Honorhealth Research Institute , Seroba Life Sciences , Beate Holz , Associate Clinical Investigator , Pfizer Ventures , Cambridge Innovation Capitali Limited , Tokyo Innovation , Storm Therapeutics ,